News » CES

Cranial electrotherapy stimulation – otherwise known as CES – is a treatment cleared by the FDA for addressing insomnia in patients. Completely non-invasive and safe, it works to encourage the brain to react appropriately to the need for rest. The severity of insomnia can vary depending on how early or late it occurs in a typical sleep cycle. Today, let’s explore in further detail...

Update: December 20, 2019 The Food and Drug Administration (FDA) has reclassified CES devices intended for the treatment of anxiety and/or insomnia from Class III to Class II medical devices. CES devices intended for the treatment of depression will remain Class III and need to file a premarket approval application (PMA) to retain clearance for depression. This article has been updated to reflect those...

Update: December 20, 2019 The Food and Drug Administration (FDA) has reclassified CES devices intended for the treatment of anxiety and/or insomnia from Class III to Class II medical devices. CES devices intended for the treatment of depression will remain Class III and need to file a premarket approval application (PMA) to retain clearance for depression. This article has been updated to reflect those...